NSPR

InspireMD, Inc.

$0.78

9.34%
SectorHealthcareIndustryMedical DevicesCountryUnited States

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Source: Yahoo Finance
AI summary

Price & performance

1M+50.0%
3M-2.5%
YTD-58.1%
1Y-53.6%
52-week range—
Beta0.51
Full chart and returns against a benchmark

Q-Score

38/ 100

Quality against peers; 50 is the peer median.

Growth46
Risk54
Performance27
Valuation62
Profitability26
Leverage35
Sentiment85
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$9M+28.1%
Net income-$48.8M
Net margin-543.3%-86.7 pts
Historical fundamentals

Red flags in filings

2active red flags
Going-concern doubtMar 18, 2026
Exchange listing noticeJul 23, 2026
Filings, findings and the timeline

Revenue exposure

84%of revenue from outside the US
Other Countries45%
United States16%
Germany14%
Regions, segments, customers and suppliers

Valuation

NSPRIndustryP/E—29.61P/S3.343.49EV/EBITDA0.0518.38P/B1.153.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 12next report, before the open
EPS estimate$-0.15
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate